Department of Health and Human Services May 26, 2005 – Federal Register Recent Federal Regulation Documents

Meeting of the Citizens' Health Care Working Group
Document Number: 05-10651
Type: Notice
Date: 2005-05-26
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
In accordance with section 10(a) of the Federal Advisory Committee Act, this notice announces a meeting and hearing of the Citizens' Health Care Working Group mandated by section 1014 of the Medicare Modernization Act.
Delegation of Authority
Document Number: 05-10572
Type: Notice
Date: 2005-05-26
Agency: Food and Drug Administration, Department of Health and Human Services
Statement Organization, Functions, and Delegation of Authority
Document Number: 05-10571
Type: Notice
Date: 2005-05-26
Agency: Office of the Secretary, Department of Health and Human Services
National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section
Document Number: 05-10542
Type: Notice
Date: 2005-05-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Center on Birth Defects and Developmental Disabilities
Document Number: 05-10541
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention (cdc), Centers for Disease Control and Prevention
Duchene and Becker Muscular Dystrophy Education and Outreach Initiative; Notice of Intent To Fund Single Eligibility Award
Document Number: 05-10540
Type: Notice
Date: 2005-05-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Coordination of Activities Between the CDC's National Immunization Program and the State and Territorial Health Officials
Document Number: 05-10538
Type: Notice
Date: 2005-05-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Public Health Emergency Preparedness
Document Number: 05-10537
Type: Notice
Date: 2005-05-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Document Number: 05-10534
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
Office of Biotechnology Activities, Office of the Director; Notice of Meeting
Document Number: 05-10533
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
Document Number: 05-10532
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Document Number: 05-10531
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Document Number: 05-10530
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-10529
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-10528
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-10527
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-10526
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-10525
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Child Health and Human Development; Notice of Meeting
Document Number: 05-10524
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Document Number: 05-10523
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 05-10522
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting
Document Number: 05-10521
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: 05-10520
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 05-10519
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Human Genome Research Institute; Notice of Closed Meeting
Document Number: 05-10518
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
National Library of Medicine; Notice of Meeting
Document Number: 05-10517
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, National Institutes of Health
Correction to a Notice of Meetings
Document Number: 05-10474
Type: Notice
Date: 2005-05-26
Agency: Department of Health and Human Services, Agency for Healthcare Research and Quality
Draft Guidance on Useful Written Consumer Medication Information
Document Number: 05-10445
Type: Notice
Date: 2005-05-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled ``Useful Written Consumer Medication Information (CMI).'' CMI is written information developed for consumers about prescription drugs that is distributed to consumers when they have prescriptions filled. The guidance discusses general issues and makes recommendations on the content of useful written CMI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.